| Neutrophil-to-lymphocyte ratio is a predictive biomarker in patients with epidermal growth factor receptor (EGFR) mutated advanced non-small cell lung cancer (NSCLC) treated … NK Yun, SJ Rouhani, CM Bestvina, EM Ritz, BA Gilmore, I Tarhoni, ... Cancers 13 (6), 1426, 2021 | 18 | 2021 |
| Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response MK Ash, PP Bhimalli, BK Cho, BB Mattamana, S Gambut, I Tarhoni, ... Cell reports 41 (11), 2022 | 14 | 2022 |
| Angiogenesis biomarkers may be useful in the management of patients with indeterminate pulmonary nodules CW Seder, JC Kubasiak, R Pithadia, S Basu, C Fhied, I Tarhoni, E Davila, ... The Annals of Thoracic Surgery 100 (2), 429-436, 2015 | 10 | 2015 |
| Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum I Tarhoni, CL Fhied, M Pool, MJ Liptay, P Bonomi, CW Seder, JA Borgia Journal of Immunoassay and Immunochemistry 39 (1), 84-98, 2018 | 9 | 2018 |
| Expression of immunomodulatory checkpoint molecules in drug-resistant neuroblastoma: an exploratory study NJ Skertich, F Chu, IAM Tarhoni, S Szajek, JA Borgia, MB Madonna Cancers 14 (3), 751, 2022 | 7 | 2022 |
| Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/− L1 directed immune checkpoint inhibition. I Tarhoni, CJ Wakefield, R Kollipara, MJ Fidler, M Batus, P Bonomi, ... Journal of immunological methods 490, 112956, 2021 | 7 | 2021 |
| Expression of programmed death ligand 1 in drug-resistant osteosarcoma: An exploratory study NJ Skertich, F Chu, IAM Tarhoni, S Szajek, JA Borgia, MB Madonna Surgery Open Science 6, 10-14, 2021 | 4 | 2021 |
| Dynamic monitoring of seroconversion using a multianalyte immunobead assay for Covid-19 CL Fhied, I Tarhoni, D Gerard, GM Lewin, H Moudgalya, JR Schneider, ... JoVE (Journal of Visualized Experiments), e63352, 2022 | 2 | 2022 |
| Changes in skeletal muscle mass during PD-1 and PD-L1 checkpoint inhibitor therapy in advanced-stage non-small cell lung cancer patients. M Multani, I Tarhoni, I Fughhi, S Basu, M Batus, PD Bonomi, MJ Fidler, ... Journal of Clinical Oncology 37 (15_suppl), e14061-e14061, 2019 | 2 | 2019 |
| Lung Cancer Stem Cells: Insights into Characterization and Regulatory Mechanisms AH Othman, M Tandon, I Tarhoni, JA Borgia, J Pratap Current Molecular Biology Reports 3, 247-253, 2017 | 2 | 2017 |
| IGF-1 and TGF-β promote EMT and angiogenesis in 3D cultures of lung adenocarcinoma cells: A pilot study I Tarhoni, GC Lobato, C Fhied, J Borgia, M Pergande, YW Chai Cancer Research 76 (14_Supplement), 1690-1690, 2016 | 2 | 2016 |
| P76. 30 The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in Patients with EGFR Mutated Advanced NSCLC S Rouhani, N Yun, C Bestvina, B Gilmore, E Ritz, I Tarhoni, M Batus, ... Journal of Thoracic Oncology 16 (3), S599-S600, 2021 | 1 | 2021 |
| The prognostic value of neutrophil-to-lymphocyte ratio in patients with epidermal growth factor receptor mutated advanced non-small cell lung cancer (NSCLC). N Yun, SJ Rouhani, B Gilmore, EM Ritz, CM Bestvina, I Tarhoni, M Batus, ... Journal of Clinical Oncology 38 (15_suppl), e21675-e21675, 2020 | 1 | 2020 |
| MINI01. 06: Circulating Angiogenesis Biomarkers are Predictive for Early Stage Non–Small Cell Lung Cancer Progression and Clinical Outcome: Topic: Pathology I Tarhoni, C Fhied, R Pithadia, CW Seder, S Basu, M Liptay, JA Borgia Journal of Thoracic Oncology 11 (11), S259-S260, 2016 | 1 | 2016 |
| Multiplexed Evaluation of Soluble Immune-Checkpoint Molecules in Sera from Metastatic NSCLC Patients Receiving Immunotherapy I Tarhoni, CL Fhied, D Gerard, JA Borgia | 1 | |
| Zucker Diabetic‐Sprague Dawley Rats Have Impaired Peri‐Implant Bone Formation, Matrix Composition, and Implant Fixation Strength KD Anderson, C Beckmann, S Heermant, FC Ko, B Dulion, I Tarhoni, ... JBMR plus 7 (11), e10819, 2023 | | 2023 |
| Human IgG glycan pattern and autoreactivity is associated with neuroinflammation in COVID-19 JR Schneider, T Shull, P Bhimalli, S Welninski, BK Cho, BB Mattamana, ... JOURNAL OF NEUROVIROLOGY 29, S30-S30, 2023 | | 2023 |
| O35 Detection of circulating HLA-E in cancer patients: Potential application in cancer immunotherapy V Kanangat, C Auger, I Tarhoni, J Borgia, M Marshalla, R DeCresce Human Immunology 84, 51-52, 2023 | | 2023 |
| Development of a microbead based immunoassay to detect circulating soluble HLA-E: Application in cancer immunobiology. V Kanangat, C Auger, I Tarhoni, MK Marshalla, D Gerard, A Abdelkader, ... Journal of Clinical Oncology 41 (16_suppl), e17606-e17606, 2023 | | 2023 |
| Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with ‘Actionable’Pulmonary Nodules C Auger, H Moudgalya, MR Neely, JT Stephan, I Tarhoni, D Gerard, ... Cancers 15 (8), 2259, 2023 | | 2023 |
Mary FidlerRushVerified email at rush.edu
